Icon

BLOXIVERZ (nda204078)- (5MG/10ML (0.5MG/ML),5MG/5ML (1MG/ML),10MG/10ML (1MG/ML))

NEOSTIGMINE METHYLSULFATE EXELA PHARMA
5MG/10ML (0.5MG/ML),5MG/5ML (1MG/ML),10MG/10ML (1MG/ML)
No Yes
Expired Expired
None None
None No
BLOXIVERZ, a cholinesterase inhibitor, is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery
16 0 12
Total Other Developers 7
Drugs with Suitability No
5MG/10ML (0.5MG/ML) ** ** - - -
5MG/5ML (1MG/ML) ** ** - - -
10MG/10ML (1MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 10
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ***** *************** *** ***. *********** * ********** ****, ****** ****, *** ****** (**) *****, ****** ****** (***) ***
****** ** ****** ***** ****** ******* *********** **** **: **-**, **, **, **-**, **. **. ***, ***, *** & ***, ***** ***, *****, ************ *******, ********** ******, ********** ********, *********, ********* ******, ***** (***) ***
****** ********* ****** *** ********* ***************, ***. *********** ***** *** ******, ****** *********, ********** (**) *****, ****** ****** (***) ***
****** ****** ****** *************** ******* ******* *********** **** **. **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***. ******, *********, ** ******, ***** (***) ***
****** ******* ****** ******** ******* *********** *** *****-** & ***, *-**,**,**, ***** ********** ****, *****, ***, *** ******, ***** (***) ***
****** ** ****** ********** *. ******* *********** **** **.*, **. **. ***/*, ******* ****, *****-**, ******* *******, ********** ******, *******, ********* ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** **: **-**, **, **, **-**, **. **. ***, ***, *** & ***, ***** ***, *****, ************ *******, ********** ******, ********** ********, *********, ********* ******, ***** (***) ***
****** ****** ****** ******** ******* *********** ****** **.*** & ***. ******************, **************** (****), *********** (********), *************, ***** **** ******, ***** (***) ***
****** **** ************ ****** *************** ******* *********** **** **. **-**, ** & **/*, ****, ****** - **, ******, *** - ******, *********, ******* ******, ***** (***) ***
****** ***** ****** ******** ****** ******* ******* *** *********** ****-**, ****** **. ** & **, ************* ******* ***- *********, ******** ******, **********, ********* ******, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ***, ** ** **, ****, *****, ***, ************ *******, ********** ******, **********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.